HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

human GAA protein (Myozyme)

Defects in the gene for this protein cause glycogen storage disease II, also known as Pompe disease, RefSeq NM_000152
Also Known As:
Myozyme; alglucosidase alfa; GAA protein, human; LYAG protein, human; Nexviazyme; acid alpha-glucosidase, human; acid maltase, human; avlglucosidase alfa; glucosidase, alpha; acid (Pompe disease, glycogen storage disease type II), human; lysosomal alpha-glucosidase, human; recombinant human acid alpha-glucosidase; rhGAA
Networked: 213 relevant articles (48 outcomes, 38 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Kishnani, Priya S: 52 articles (09/2022 - 08/2005)
2. van der Ploeg, Ans T: 13 articles (01/2022 - 04/2010)
3. Schoser, Benedikt: 12 articles (12/2021 - 10/2008)
4. Thurberg, Beth L: 11 articles (01/2019 - 11/2004)
5. Young, Sarah P: 9 articles (01/2020 - 08/2005)
6. Bali, Deeksha: 9 articles (07/2019 - 12/2008)
7. Rosenberg, Amy S: 9 articles (07/2019 - 08/2011)
8. Byrne, Barry J: 8 articles (03/2022 - 06/2012)
9. Koeberl, Dwight D: 8 articles (01/2021 - 12/2008)
10. Case, Laura E: 8 articles (01/2020 - 05/2007)

Related Diseases

1. Glycogen Storage Disease Type II (Pompe's Disease)
2. Cardiomyopathies (Cardiomyopathy)
3. Muscular Diseases (Myopathy)
4. Anaphylaxis (Anaphylactic Shock)
5. Tachypnea

Related Drugs and Biologics

1. human GAA protein (Myozyme)
2. alpha-Glucosidases (Acid Maltase)
3. Acids
4. Enzymes
5. Glucosidases
6. Antibodies
7. Glycogen
8. miglustat (Zavesca)
9. Ligands
10. Antioxidants

Related Therapies and Procedures

1. Enzyme Replacement Therapy
2. Mechanical Ventilators (Ventilator)
3. Therapeutics
4. Enzyme Therapy
5. Immunomodulation